Psychemedics Named “Most Innovative Drug Testing Company of the Year”
Psychemedics Corporation (PMD), the world's leading hair drug testing provider, has been awarded "Most Innovative Drug Testing Company of the Year" by Acquisition International Magazine in their 2025 Global Excellence Awards. The company recently launched its Enhanced Quartile Reporting, a breakthrough analytics tool that provides deeper insights into drug use severity and behavioral risk patterns by placing positive results into population-based quartiles.
CEO Brian Hullinger emphasized that this recognition validates their commitment to innovation and scientific advancement. The company's hair testing technology is distinguished by its detection sensitivity, tamper resistance, and detection window length, serving Fortune 500 companies, law enforcement, schools, and insurers. The Enhanced Quartile Reporting system particularly benefits high-risk industries like transportation, oil and gas, and insurance by enabling more informed safety and risk management decisions.
Psychemedics Corporation (PMD), leader mondiale nei test antidroga su capelli, è stata premiata come "Azienda di Test Antidroga Più Innovativa dell'Anno" da Acquisition International Magazine nei loro Global Excellence Awards 2025. Recentemente, l'azienda ha lanciato il suo Enhanced Quartile Reporting, uno strumento analitico rivoluzionario che offre approfondimenti più dettagliati sulla gravità dell'uso di sostanze e sui modelli comportamentali di rischio, collocando i risultati positivi in quartili basati sulla popolazione.
Il CEO Brian Hullinger ha sottolineato che questo riconoscimento conferma il loro impegno per l'innovazione e il progresso scientifico. La tecnologia di test sui capelli dell'azienda si distingue per la sua sensibilità di rilevamento, resistenza alla manomissione e durata della finestra di rilevamento, servendo aziende Fortune 500, forze dell'ordine, scuole e assicuratori. Il sistema Enhanced Quartile Reporting è particolarmente vantaggioso per settori ad alto rischio come trasporti, petrolio e gas, e assicurazioni, permettendo decisioni più informate in materia di sicurezza e gestione del rischio.
Psychemedics Corporation (PMD), el principal proveedor mundial de pruebas de drogas en cabello, ha sido galardonado como la "Empresa de Pruebas de Drogas Más Innovadora del Año" por Acquisition International Magazine en sus Global Excellence Awards 2025. Recientemente, la compañía lanzó su Enhanced Quartile Reporting, una herramienta analítica innovadora que ofrece una visión más profunda sobre la gravedad del consumo de drogas y los patrones de riesgo conductual, clasificando los resultados positivos en cuartiles basados en la población.
El CEO Brian Hullinger destacó que este reconocimiento valida su compromiso con la innovación y el avance científico. La tecnología de pruebas capilares de la empresa se distingue por su sensibilidad de detección, resistencia a la manipulación y duración de la ventana de detección, atendiendo a empresas Fortune 500, fuerzas del orden, escuelas y aseguradoras. El sistema Enhanced Quartile Reporting beneficia especialmente a industrias de alto riesgo como transporte, petróleo y gas, y seguros, permitiendo decisiones más informadas en seguridad y gestión de riesgos.
Psychemedics Corporation (PMD)는 세계 최고의 모발 약물 검사 제공업체로, Acquisition International Magazine의 2025 글로벌 엑설런스 어워드에서 "올해의 가장 혁신적인 약물 검사 회사"로 선정되었습니다. 회사는 최근 Enhanced Quartile Reporting을 출시했으며, 이는 양성 결과를 인구 기반 사분위수로 분류하여 약물 사용 심각도와 행동 위험 패턴에 대한 더 깊은 통찰을 제공하는 획기적인 분석 도구입니다.
CEO 브라이언 헐링거는 이 수상이 혁신과 과학적 진보에 대한 그들의 헌신을 입증한다고 강조했습니다. 회사의 모발 검사 기술은 감지 민감도, 변조 방지 및 감지 기간의 길이로 차별화되며, Fortune 500 기업, 법 집행 기관, 학교 및 보험사에 서비스를 제공합니다. Enhanced Quartile Reporting 시스템은 특히 운송, 석유 및 가스, 보험과 같은 고위험 산업에서 안전 및 위험 관리 결정을 보다 정보에 기반해 내릴 수 있도록 돕습니다.
Psychemedics Corporation (PMD), leader mondial des tests capillaires de dépistage de drogues, a été récompensée comme "Entreprise de Tests de Drogues la Plus Innovante de l'Année" par Acquisition International Magazine lors des Global Excellence Awards 2025. La société a récemment lancé son Enhanced Quartile Reporting, un outil analytique révolutionnaire qui offre des analyses approfondies sur la gravité de la consommation de drogues et les comportements à risque en classant les résultats positifs selon des quartiles basés sur la population.
Le PDG Brian Hullinger a souligné que cette reconnaissance confirme leur engagement envers l'innovation et le progrès scientifique. La technologie de test capillaire de l'entreprise se distingue par sa sensibilité de détection, sa résistance à la falsification et la durée de sa fenêtre de détection, desservant des entreprises du Fortune 500, les forces de l'ordre, les écoles et les assureurs. Le système Enhanced Quartile Reporting bénéficie particulièrement aux secteurs à haut risque comme le transport, le pétrole et le gaz, ainsi que l'assurance, en permettant des décisions plus éclairées en matière de sécurité et de gestion des risques.
Psychemedics Corporation (PMD), der weltweit führende Anbieter von Haar-Drogentests, wurde von Acquisition International Magazine bei den Global Excellence Awards 2025 als "Innovativstes Drogentestunternehmen des Jahres" ausgezeichnet. Das Unternehmen hat kürzlich sein Enhanced Quartile Reporting eingeführt, ein bahnbrechendes Analysetool, das tiefere Einblicke in die Schwere des Drogenkonsums und Verhaltensrisikomuster bietet, indem positive Ergebnisse in bevölkerungsbasierte Quartile eingeordnet werden.
CEO Brian Hullinger betonte, dass diese Anerkennung ihr Engagement für Innovation und wissenschaftlichen Fortschritt bestätigt. Die Haar-Testtechnologie des Unternehmens zeichnet sich durch hohe Nachweisempfindlichkeit, Manipulationssicherheit und lange Nachweisfenster aus und bedient Fortune-500-Unternehmen, Strafverfolgungsbehörden, Schulen und Versicherer. Das Enhanced Quartile Reporting-System ist besonders vorteilhaft für risikoreiche Branchen wie Transport, Öl und Gas sowie Versicherungen, da es fundiertere Entscheidungen in Bezug auf Sicherheit und Risikomanagement ermöglicht.
- None.
- None.
DALLAS, May 16, 2025 (GLOBE NEWSWIRE) -- Psychemedics Corporation, the world’s leading provider of hair drug testing, is proud to announce it has been named “Most Innovative Drug Testing Company of the Year” by Acquisition International Magazine as part of its prestigious 2025 Global Excellence Awards.
This recognition honors Psychemedics’ continued leadership in advancing the science of drug detection, including the recent launch of its Enhanced Quartile Reporting. This breakthrough analytics tool provides deeper insights into the severity of drug use and behavioral risk patterns.
“Being recognized as the most innovative drug testing company of the year is a powerful validation of our team’s commitment to science, research, and client success,” said Brian Hullinger, President and CEO of Psychemedics. “Innovation is at the core of everything we do, whether advancing the reliability of our testing or providing actionable insights that help our clients make better hiring and risk decisions.”
Enhanced Quartile Reporting provides a new level of interpretive value by placing positive results into population-based quartiles, offering employers and partners greater context about where an individual’s result falls relative to others. This added layer of insight helps organizations in high-risk industries, such as transportation, oil and gas, and insurance, make more informed decisions around safety and risk management.
Hullinger continued, “Our Enhanced Quartile Reporting is just one example of how we’re helping organizations move beyond basic drug testing to true behavioral risk assessment. We appreciate the recognition of our ongoing efforts to elevate the standards of workplace and public safety.”
Psychemedics’ hair testing technology remains unmatched in detection sensitivity, tamper resistance, and detection window length, making it the trusted solution for Fortune 500 companies, law enforcement, schools, and insurers.
For more information about Psychemedics Corporation and its innovative hair testing solutions, please visit https://www.psychemedics.com.
About Psychemedics
Psychemedics Corporation is a leading global provider of innovative hair testing for drugs of abuse. With a commitment to accuracy and reliability, the company offers cutting-edge drug testing solutions. Psychemedics Corporation is dedicated to providing valuable insights and maintaining the highest standards in substance abuse testing.
Investor Relations:
Phone: 978-206-8220
Email: InvestorRelations@psychemedics.com
FAQ
What award did Psychemedics (PMD) receive in 2025?
What is Psychemedics' Enhanced Quartile Reporting system?
Who is the CEO of Psychemedics Corporation?
What industries does Psychemedics (PMD) serve?
What are the key advantages of Psychemedics' hair testing technology?
